BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30772513)

  • 1. Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant.
    Higgins A; Khan Z; Coddington CC; Hashmi SK; Hefazi M; Alkhateeb H; Litzow MR; Hogan WJ; Cathcart-Rake E; Thompson CA; Patnaik MM
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1232-1239. PubMed ID: 30772513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility Potential and Gonadal Function in Survivors of Reduced-Intensity Hematopoietic Stem Cell Transplantation.
    Rotz SJ; Hamilton BK; Wei W; Ahmed I; Winston SA; Ballard S; Bernard RJ; Carpenter P; Farhadfar N; Ferraro C; Friend BD; Gloude NJ; Hayashi RJ; Hoyle K; Jenssen K; Koo J; Lee CJ; Mariano L; Nawabit R; Ngwube A; Lalefar N; Phelan R; Perkins L; Rao A; Rayes A; Sandheinrich T; Stafford L; Tomlinson K; Whiteside S; Wiedl C; Myers K
    Transplant Cell Ther; 2024 May; 30(5):534.e1-534.e13. PubMed ID: 38342136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Surgical Fertility Preservation Procedures in Children Prior to Hematopoietic Stem Cell Transplant.
    Brodigan K; Kapadia M; Frazier AL; Laufer MR; Yu R; Weil BR; Ginsburg ES; Duncan C; Lehmann L
    Transplant Cell Ther; 2021 Aug; 27(8):696.e1-696.e4. PubMed ID: 33864966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexuality- and Fertility-Related Issues in Women after Allogeneic Hematopoietic Stem Cell Transplantation.
    Forgeard N; Jestin M; Vexiau D; Chevillon F; Ricadat E; Peffault de Latour R; Robin M; Sicre de Fontbrune F; Xhaard A; Michonneau D; Boissel N; Poirot C; Dhédin N
    Transplant Cell Ther; 2021 May; 27(5):432.e1-432.e6. PubMed ID: 33789835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical guide to fertility preservation in hematopoietic cell transplant recipients.
    Joshi S; Savani BN; Chow EJ; Gilleece MH; Halter J; Jacobsohn DA; Pidala J; Quinn GP; Cahn JY; Jakubowski AA; Kamani NR; Lazarus HM; Rizzo JD; Schouten HC; Socie G; Stratton P; Sorror ML; Warwick AB; Wingard JR; Loren AW; Majhail NS
    Bone Marrow Transplant; 2014 Apr; 49(4):477-84. PubMed ID: 24419521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of allogeneic haemopoietic stem cell transplants at a small New Zealand centre: does size matter?
    Ganly P; Cole S; Trengrove A; Butler A
    Intern Med J; 2014 Jul; 44(7):683-9. PubMed ID: 24750295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental perspective on the risk of infertility and fertility preservation options for children and adolescents with sickle cell disease considering hematopoietic stem cell transplantation.
    Sinha CB; Meacham LR; Bakshi N; Ross D; Krishnamurti L
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30276. PubMed ID: 37051746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women.
    Lee YJ; Kim JS; Jo JC; Kim Y; Im HS; Kim H; Koh S; Min YJ; Park SH; Ahn JW; Choi Y
    Eur J Haematol; 2023 Sep; 111(3):449-457. PubMed ID: 37308461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting.
    Guru Murthy GS; Hari PN; Szabo A; Pasquini M; Narra R; Khan M; Abedin S; Chhabra S; Dhakal B; D'Souza A; Drobyski WR; Rizzo JD; Runaas L; Shah NN; Shaw B; Saber W; Fenske T; Hamadani M
    Biol Blood Marrow Transplant; 2019 Apr; 25(4):827-833. PubMed ID: 30572109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation.
    Solh MM; Solomon SR; Morris LE; Zhang X; Holland HK; Bashey A
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):606-612. PubMed ID: 30244109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplantation.
    Bender JD; Oquendo-Del Toro H; Benoit J; Howell JC; Badia P; Davies SM; Grimley MS; Jodele S; Phillips C; Burns K; Marsh R; Nelson A; Wallace G; Dandoy CE; Pate A; Strine AC; Frias O; Breech L; Rose SR; Hoefgen H; Khandelwal P; Myers KC
    Transplant Cell Ther; 2023 Feb; 29(2):130.e1-130.e8. PubMed ID: 36323400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).
    Loren AW; Chow E; Jacobsohn DA; Gilleece M; Halter J; Joshi S; Wang Z; Sobocinski KA; Gupta V; Hale GA; Marks DI; Stadtmauer EA; Apperley J; Cahn JY; Schouten HC; Lazarus HM; Savani BN; McCarthy PL; Jakubowski AA; Kamani NR; Hayes-Lattin B; Maziarz RT; Warwick AB; Sorror ML; Bolwell BJ; Socié G; Wingard JR; Rizzo JD; Majhail NS
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):157-66. PubMed ID: 20659574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning.
    Phelan R; Mann E; Napurski C; DeFor TE; Petryk A; Miller WP; Wagner JE; Verneris MR; Smith AR
    Bone Marrow Transplant; 2016 Oct; 51(10):1369-1375. PubMed ID: 27272448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic Cell Transplantation and Utilization of Fertility Preservation Services.
    Hwee T; Bergen K; Leppke S; Silver A; Loren A
    Biol Blood Marrow Transplant; 2019 May; 25(5):989-994. PubMed ID: 30625390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.
    Chhabra S; Ahn KW; Hu ZH; Jain S; Assal A; Cerny J; Copelan EA; Daly A; DeFilipp Z; Gadalla SM; Gale RP; Ganguly S; Hamilton BK; Hildebrandt GC; Hsu JW; Inamoto Y; Kanate AS; Khoury HJ; Lazarus HM; Litzow MR; Nathan S; Olsson RF; Pawarode A; Ringden O; Rowe JM; Saad A; Savani BN; Schouten HC; Seo S; Shah NN; Solh M; Stuart RK; Ustun C; Woolfrey AE; Yared JA; Alyea EP; Kalaycio ME; Popat U; Sobecks RM; Saber W
    Blood Adv; 2018 Nov; 2(21):2922-2936. PubMed ID: 30396912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine/Melphalan 100 mg/m
    Park HS; Lee JH; Lee JH; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Lee KH
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1116-1121. PubMed ID: 30508593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.